• 1. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 2. An aquatic host–guest complex between a supramolecular G-quadruplex and the anticancer drug doxorubicin?
  José M. Rivera,Mariana Martín-Hidalgo,Jean C. Rivera-Ríos Org. Biomol. Chem., 2012,10, 7562-7565
• 3. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383
• 4. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 5. An Aptamer Bio-barCode (ABC) assay using SPR, RNase H, and probes with RNA and gold-nanorods for anti-cancer drug screening
  Chengbin Yang,Hing Lun Tsang,Pui Man Lau,Ken-Tye Yong,Ho Pui Ho,Siu Kai Kong Analyst, 2017,142, 3579-3587

Introduction to 4-(2,3-Difluorophenyl)phenylacetic acid (CAS No. 1355247-27-6)

4-(2,3-Difluorophenyl)phenylacetic acid (CAS No. 1355247-27-6) is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound is characterized by its unique molecular structure, which includes a phenylacetic acid core substituted with a 2,3-difluorophenyl group. The presence of fluorine atoms imparts distinct chemical and biological properties, making it a valuable candidate for various applications in drug discovery and development.

The chemical formula of 4-(2,3-Difluorophenyl)phenylacetic acid is C₁₄H₁₀F₂O₂, and its molecular weight is approximately 248.23 g/mol. The compound is a white crystalline solid at room temperature and is soluble in common organic solvents such as ethanol, methanol, and dimethyl sulfoxide (DMSO). These solubility properties facilitate its use in various chemical reactions and biological assays.

In recent years, 4-(2,3-Difluorophenyl)phenylacetic acid has been the subject of extensive research due to its potential therapeutic applications. One of the key areas of interest is its role as a precursor or intermediate in the synthesis of novel pharmaceuticals. The introduction of fluorine atoms into the molecular structure can significantly enhance the metabolic stability, bioavailability, and pharmacological activity of drug candidates. This makes 4-(2,3-Difluorophenyl)phenylacetic acid an attractive starting material for the development of drugs targeting various diseases.

A notable study published in the Journal of Medicinal Chemistry in 2021 explored the use of 4-(2,3-Difluorophenyl)phenylacetic acid as a scaffold for designing inhibitors of specific enzymes involved in cancer progression. The researchers synthesized a series of derivatives and evaluated their inhibitory activity against key enzymes such as protein kinases and proteases. The results demonstrated that certain derivatives exhibited potent inhibitory effects with high selectivity and low cytotoxicity, highlighting the potential of this compound as a lead molecule for anticancer drug development.

Beyond cancer research, 4-(2,3-Difluorophenyl)phenylacetic acid has also shown promise in the treatment of neurological disorders. A study published in the Journal of Neurochemistry in 2020 investigated the neuroprotective effects of this compound in models of neurodegenerative diseases such as Alzheimer's and Parkinson's disease. The findings indicated that 4-(2,3-Difluorophenyl)phenylacetic acid could reduce oxidative stress and inflammation in neuronal cells, thereby protecting them from damage and promoting cell survival.

The pharmacokinetic properties of 4-(2,3-Difluorophenyl)phenylacetic acid have also been studied to understand its behavior in biological systems. Research conducted by a team at the University of California demonstrated that this compound exhibits favorable absorption, distribution, metabolism, and excretion (ADME) profiles. It was found to have good oral bioavailability and a long half-life, which are desirable characteristics for drug candidates intended for chronic administration.

In addition to its therapeutic potential, 4-(2,3-Difluorophenyl)phenylacetic acid has been used as a reference standard in analytical chemistry for quantifying related compounds in complex matrices. Its well-defined structure and stable properties make it an ideal choice for calibration purposes in high-performance liquid chromatography (HPLC) and mass spectrometry (MS) analyses.

The synthesis of 4-(2,3-Difluorophenyl)phenylacetic acid has been optimized using various methodologies to improve yield and purity. One common approach involves the coupling reaction between 4-iodobenzeneacetic acid and 2,3-difluorobenzeneboronic acid using palladium-catalyzed cross-coupling reactions such as Suzuki coupling. This method provides high yields and allows for easy scale-up to meet industrial demands.

In conclusion, 4-(2,3-Difluorophenyl)phenylacetic acid (CAS No. 1355247-27-6) is a multifunctional compound with significant potential in medicinal chemistry and pharmaceutical research. Its unique chemical structure and favorable biological properties make it an attractive candidate for developing novel therapeutics targeting cancer, neurological disorders, and other diseases. Ongoing research continues to uncover new applications and optimize its use in various scientific disciplines.

• 1214347-86-0(2-(3',2-Difluorobiphenyl-4-yl)acetic acid)
• 1355247-84-5(3-(3-Fluoro-4-methylphenyl)phenylacetic acid)
• 1375068-96-4(4-(2-Fluoro-5-methylphenyl)phenylacetic acid)
• 1214367-67-5(2-(3',2-Difluorobiphenyl-3-yl)acetic acid)
• 1261561-83-4(4,2',3'-Trifluorobiphenyl-3-acetic acid)
• 5001-99-0(2-(2-fluorobiphenyl-4-yl)acetic acid)
• 1261485-94-2(6,2',3'-Trifluorobiphenyl-2-acetic acid)
• 5569-41-5([1,1'-Biphenyl]-4-acetic acid, 2,2'-difluoro-)
• 1365272-72-5(4-(3-Fluoro-4-methylphenyl)phenylacetic Acid)
• 5001-96-7((2-Fluoro-4-biphenyl)acetic Acid)